Controle da hipertensão arterial e fatores associados na atenção primária em Unidades Básicas de Saúde localizadas na Região Oeste da cidade de São Paulo

Pierin, Ângela Maria Geraldo; Marroni, Sandra Nara; Taveira, Luzi Aparecida Faleiros; Benseñor, Isabela Judith Martins

doi:10.1590/s1413-81232011000700074

Cited by 42 publications

(69 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[15] Hypertension is considered major cardiovascular risk factor by associating often to metabolic changes and target organ damages. [22] A low level of HDL-C was the second most prevalent component of MS among women who had previous PE, converging with results from another study that found similar values. [20] It is also noteworthy that such component provides protective properties in prevention of CVD.…”

Section: Discussionsupporting

confidence: 70%

“…This is worrisome, since hypertension is considered major cardiovascular risk factor by associating often on metabolic disorders and target organ damage. [22] Thus, individuals presenting this blood pressure range already have cardiovascular and kidney disease established. [15] Hypertension is considered major cardiovascular risk factor by associating often to metabolic changes and target organ damages.…”

Section: Discussionmentioning

confidence: 99%

“…In this sense, its reduction is associated to the onset of ischemic heart disease independently of other cardiovascular risk factors. [22] As concerns glycemia ≥ 100 mg/dL, the third most prevalent SM component in women who had PE history, compared to usual risk pregnancy, it deserves attention as a risk factor because of their association as a marker of diabetes mellitus and cardiovascular risk. Similar data were also found in other investigations.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Metabolic Syndrome: Individual Components in Women who Had Preeclampsia History and Normal Risk Pregnancy

et al. 2016

View full text Add to dashboard Cite

Introduction: Preeclampsia is a serious complication of pregnancy and childbirth that can contribute to the late onset of cardiovascular risk factors, among which the metabolic syndrome.Objective: Identifying the prevalence of metabolic syndrome and its individual components in women who had preeclampsia and normal risk of pregnancy, evaluated five years after delivery.Method: Analytical and descriptive, cross-sectional study with data collection conducted from March to December 2011 in a maternity hospital school, Natal-RN-Brazil. The sample included 70 women who had previous preeclampsia and 75 with normal pregnancy, selected by simple random probability sampling method.Results: It appeared as a cardiovascular risk factor, with statistical significance for metabolic syndrome p = 0.042, but also the fasting glucose levels p = 0.030, HDL cholesterol p = 0.049, systolic and diastolic pressure p <0.001. Conclusion:Therefore, preeclampsia appears as a potential risk factor for metabolic syndrome, hence as long-term cardiovascular risk factor.

show abstract

Section: Discussionsupporting

confidence: 70%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Metabolic Syndrome: Individual Components in Women who Had Preeclampsia History and Normal Risk Pregnancy

et al. 2016

View full text Add to dashboard Cite

show abstract

“…This control is positive, because sodium intake is directly related to increased blood pressure, which is corroborated by Pierin and colleagues, who evaluated hypertension control and associated factors (Pierin et al, 2011). However, the present study did not investigate whether the non-pharmacological measures were adequate for the control of blood pressure levels.…”

Section: Discussionsupporting

confidence: 49%

Pharmacotherapy review: a proposal to improve medication adherence among hypertensive patients

Rigoni

Brito

Alano

et al. 2015

Braz. J. Pharm. Sci.

View full text Add to dashboard Cite

Pharmacotherapy review is a structured assessment of medicines, which aims to obtain a partnership with patients to achieve drug treatment goals and agreement about drug dosage, as well as when and how the drugs should be administered. The objective was to analyze the influence of pharmacotherapy review, by scheduling drug administration to improve medication adherence among antihypertensive patients. This study was an uncontrolled intervention developed in three distinct stages. The first stage included data collection on the profile of patients and their medications, and a preliminary assessment of medication adherence. In the second stage, the review report was delivered to patients. In the third stage, the results of blood pressure and medication adherence were assessed. The influence of the revision was measured through statistical tests (p<0.05). The study included 40 patients with a mean age of 58.0 (SD:11.3) years; 72.5% were women. Thirty-three (82.5 %) patients required some intervention, after when there was a significant increase in the number of daily doses (p=0.039) and drug intakes (p=0.025). There was a significant increase in the adherence rate, according to both the Morisky-Green test (p<0.001) and self-reported assessment (p=0.004). There was also an improvement in the levels of systolic (p<0.001) and diastolic (p=0.002) blood pressure and in the number of patients with controlled hypertension (p=0.006). The pharmaceutical service enhanced medication adherence and control of systemic blood pressure; however, it increased the complexity of treatment.Uniterms: Pharmacotherapy review. Drugs/administration schedule. Hypertension/medication adherence. Medication adherence. Pharmaceutical assistance.A revisão da farmacoterapia é uma avaliação estruturada dos medicamentos com o objetivo de proporcionar aos pacientes o alcance dos objetivos terapêuticos por meio da forma adequada de administração dos medicamentos. O objetivo foi analisar a influência da revisão da farmacoterapia, por meio do aprazamento dos medicamentos, na adesão à medicação e no controle da hipertensão arterial sistêmica. Trata-se de um estudo de intervenção não controlado desenvolvido em três momentos distintos. No primeiro, realizou-se a coleta de dados sobre o perfil dos pacientes e de suas medicações e a avaliação da adesão; no segundo momento, realizou-se a entrega do relatório da revisão aos pacientes e na terceira etapa avaliou-se o resultado da adesão e pressão arterial. A influência da revisão foi medida por meio de testes estatísticos (p<0,05). Participaram deste estudo 40 pacientes, com média de idade de 58,0 anos (SD:11,3), sendo 72,5% mulheres. Dos pacientes, 33 (82,5%) necessitaram intervenções. Após estas se verificou aumento significativo no número de doses (p=0,039) e no número de tomadas (p=0,025). Houve aumento significativo no número de aderentes tanto pelo teste de Morisky-Green (p<0,001) quanto na avaliação autorreferida (p=0,004). Também, houve melhora nos níveis de pressão sistólica (p<0,001) e diastólica (p=...

show abstract

“…De forma similar, estudo mais recente, também observou que homens tendem a serem menos aderentes ao tratamento antihipertensivo (PIERIN et al, 2011).…”

Section: Fatores Que Influenciam à Não Adesão Ao Tratamento Anti-hipeunclassified

Fatores Associados a Não Adesão Ao Tratamento Da Hipertensão Arterial Sistêmica: Uma Revisão Integrativa

et al. 2014

View full text Add to dashboard Cite

Controle da hipertensão arterial e fatores associados na atenção primária em Unidades Básicas de Saúde localizadas na Região Oeste da cidade de São Paulo

Cited by 42 publications

References 17 publications

Metabolic Syndrome: Individual Components in Women who Had Preeclampsia History and Normal Risk Pregnancy

Metabolic Syndrome: Individual Components in Women who Had Preeclampsia History and Normal Risk Pregnancy

Pharmacotherapy review: a proposal to improve medication adherence among hypertensive patients

Fatores Associados a Não Adesão Ao Tratamento Da Hipertensão Arterial Sistêmica: Uma Revisão Integrativa

Contact Info

Product

Resources

About